Combination of αPD-1 and extended half-life IL-2 is effective against the GL261 glioma and uniquely reverses GBM-associated immunosuppression
Year: 2022
Type: conference-abstract
Source: The Journal of Immunology
Authors: Zachariah Peter Tritz, Katayoun Ayasoufi, Courtney Sarah Malo, Benjamin Himes, Alexi Zastrow, Delaney Wolf, Emma Goddery, Roman Khadka, Cori Fain, Maggie Chen, Lila T Yokanovich, Fang Jin, Michael Hansen, Chensu Wang, Kelly Moynihan, Darrell J Irvine, K Dane Wittrup, Ian F Parney, Aaron J Johnson
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4313430114